Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies. / Odarenko, Kirill V; Zenkova, Marina A; Markov, Andrey V.
в: International Journal of Molecular Sciences, Том 24, № 24, 17325, 12.2023.Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
}
TY - JOUR
T1 - The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies
AU - Odarenko, Kirill V
AU - Zenkova, Marina A
AU - Markov, Andrey V
N1 - This research was funded by the Russian Science Foundation, grant number 19-74-30011.
PY - 2023/12
Y1 - 2023/12
N2 - Lung cancer is the leading cause of cancer-related death worldwide. Its high mortality is partly due to chronic inflammation that accompanies the disease and stimulates cancer progression. In this review, we analyzed recent studies and highlighted the role of the epithelial-mesenchymal transition (EMT) as a link between inflammation and lung cancer. In the inflammatory tumor microenvironment (iTME), fibroblasts, macrophages, granulocytes, and lymphocytes produce inflammatory mediators, some of which can induce EMT. This leads to increased invasiveness of tumor cells and self-renewal of cancer stem cells (CSCs), which are associated with metastasis and tumor recurrence, respectively. Based on published data, we propose that inflammation-induced EMT may be a potential therapeutic target for the treatment of lung cancer. This prospect is partially realized in the development of EMT inhibitors based on pentacyclic triterpenoids (PTs), described in the second part of our study. PTs reduce the metastatic potential and stemness of tumor cells, making PTs promising candidates for lung cancer therapy. We emphasize that the high diversity of molecular mechanisms underlying inflammation-induced EMT far exceeds those that have been implicated in drug development. Therefore, analysis of information on the relationship between the iTME and EMT is of great interest and may provide ideas for novel treatment approaches for lung cancer.
AB - Lung cancer is the leading cause of cancer-related death worldwide. Its high mortality is partly due to chronic inflammation that accompanies the disease and stimulates cancer progression. In this review, we analyzed recent studies and highlighted the role of the epithelial-mesenchymal transition (EMT) as a link between inflammation and lung cancer. In the inflammatory tumor microenvironment (iTME), fibroblasts, macrophages, granulocytes, and lymphocytes produce inflammatory mediators, some of which can induce EMT. This leads to increased invasiveness of tumor cells and self-renewal of cancer stem cells (CSCs), which are associated with metastasis and tumor recurrence, respectively. Based on published data, we propose that inflammation-induced EMT may be a potential therapeutic target for the treatment of lung cancer. This prospect is partially realized in the development of EMT inhibitors based on pentacyclic triterpenoids (PTs), described in the second part of our study. PTs reduce the metastatic potential and stemness of tumor cells, making PTs promising candidates for lung cancer therapy. We emphasize that the high diversity of molecular mechanisms underlying inflammation-induced EMT far exceeds those that have been implicated in drug development. Therefore, analysis of information on the relationship between the iTME and EMT is of great interest and may provide ideas for novel treatment approaches for lung cancer.
KW - Humans
KW - Lung Neoplasms/drug therapy
KW - Triterpenes/pharmacology
KW - Signal Transduction
KW - Neoplasm Recurrence, Local/pathology
KW - Epithelial-Mesenchymal Transition
KW - Inflammation/drug therapy
KW - Pentacyclic Triterpenes/therapeutic use
KW - Neoplastic Stem Cells/pathology
KW - Tumor Microenvironment
KW - aggressiveness
KW - tumor stem cells
KW - mechanism of action
KW - epithelial-to-mesenchymal transition
KW - natural products
KW - inflammation
KW - pulmonary malignancy
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85180665722&origin=inward&txGid=bd64f7ac4ffc49857fbef9ca532f3e0e
UR - https://www.mendeley.com/catalogue/9ea4fa06-ee79-3ea8-bd70-a0a49348008a/
U2 - 10.3390/ijms242417325
DO - 10.3390/ijms242417325
M3 - Review article
C2 - 38139154
VL - 24
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1661-6596
IS - 24
M1 - 17325
ER -
ID: 59536282